Home

zdieľam pokuta plutva plasma microrna 133a is a new marker rada maxima holenie

Plasma microRNA-133a is a new marker for both acute myocardial infarction  and underlying coronary artery stenosis | Journal of Translational Medicine  | Full Text
Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis | Journal of Translational Medicine | Full Text

Plasma Circulating Extracellular RNAs in Left Ventricular Remodeling  Post-Myocardial Infarction - eBioMedicine
Plasma Circulating Extracellular RNAs in Left Ventricular Remodeling Post-Myocardial Infarction - eBioMedicine

Increased MicroRNA-1 and MicroRNA-133a Levels in Serum of Patients With  Cardiovascular Disease Indicate Myocardial Damage | Circulation:  Cardiovascular Genetics
Increased MicroRNA-1 and MicroRNA-133a Levels in Serum of Patients With Cardiovascular Disease Indicate Myocardial Damage | Circulation: Cardiovascular Genetics

Plasma microRNA-133a is a new marker for both acute myocardial infarction  and underlying coronary artery stenosis | Journal of Translational Medicine  | Full Text
Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis | Journal of Translational Medicine | Full Text

Up-regulated miR-133a orchestrates epithelial-mesenchymal transition of  airway epithelial cells | Scientific Reports
Up-regulated miR-133a orchestrates epithelial-mesenchymal transition of airway epithelial cells | Scientific Reports

Twelve-month kinetics of circulating fibrosis-linked microRNAs (miR-21, miR-29,  miR-30, and miR-133a) and the relationship with extracellular matrix  fibrosis in dilated cardiomyopathy
Twelve-month kinetics of circulating fibrosis-linked microRNAs (miR-21, miR-29, miR-30, and miR-133a) and the relationship with extracellular matrix fibrosis in dilated cardiomyopathy

MicroRNAs and Myocardial Infarct: Investigating the Controversial Role of  Second Generation Biomarkers. | Semantic Scholar
MicroRNAs and Myocardial Infarct: Investigating the Controversial Role of Second Generation Biomarkers. | Semantic Scholar

miR-223-3p and miR-24-3p as novel serum-based biomarkers for myotonic  dystrophy type 1: Molecular Therapy - Methods & Clinical Development
miR-223-3p and miR-24-3p as novel serum-based biomarkers for myotonic dystrophy type 1: Molecular Therapy - Methods & Clinical Development

MicroRNAs in cardiovascular disease - ScienceDirect
MicroRNAs in cardiovascular disease - ScienceDirect

Plasma MicroRNA-133a as a Potential Biomarker for Acute Coronary Syndrome
Plasma MicroRNA-133a as a Potential Biomarker for Acute Coronary Syndrome

Disparate miRNA expression in serum and plasma of patients with acute  myocardial infarction: a systematic and paired comparative analysis |  Scientific Reports
Disparate miRNA expression in serum and plasma of patients with acute myocardial infarction: a systematic and paired comparative analysis | Scientific Reports

Plasma MicroRNA-133a as a Potential Biomarker for Acute Coronary Syndrome
Plasma MicroRNA-133a as a Potential Biomarker for Acute Coronary Syndrome

MicroRNA plasma expression over time. A miR-1, B miR-133a, C miR-30a, D...  | Download Scientific Diagram
MicroRNA plasma expression over time. A miR-1, B miR-133a, C miR-30a, D... | Download Scientific Diagram

Plasma microRNA-133a is a new marker for both acute myocardial infarction  and underlying coronary artery stenosis | Journal of Translational Medicine  | Full Text
Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis | Journal of Translational Medicine | Full Text

microRNA‐based diagnostic and therapeutic applications in cancer medicine -  Sempere - 2021 - WIREs RNA - Wiley Online Library
microRNA‐based diagnostic and therapeutic applications in cancer medicine - Sempere - 2021 - WIREs RNA - Wiley Online Library

Frontiers | miR-133: A Suppressor of Cardiac Remodeling?
Frontiers | miR-133: A Suppressor of Cardiac Remodeling?

Cells | Free Full-Text | MicroRNAs in Cardiac Diseases
Cells | Free Full-Text | MicroRNAs in Cardiac Diseases

Systematic review and network analysis of microRNAs involved in  cardioprotection against myocardial ischemia/reperfusion injury and  infarction: Involvement of redox signalling - ScienceDirect
Systematic review and network analysis of microRNAs involved in cardioprotection against myocardial ischemia/reperfusion injury and infarction: Involvement of redox signalling - ScienceDirect

Plasma microRNA-133a is a new marker for both acute myocardial infarction  and underlying coronary artery stenosis | Journal of Translational Medicine  | Full Text
Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis | Journal of Translational Medicine | Full Text

Increased MicroRNA-1 and MicroRNA-133a Levels in Serum of Patients With  Cardiovascular Disease Indicate Myocardial Damage | Circulation:  Cardiovascular Genetics
Increased MicroRNA-1 and MicroRNA-133a Levels in Serum of Patients With Cardiovascular Disease Indicate Myocardial Damage | Circulation: Cardiovascular Genetics

Identification of cardiac-related circulating microRNA profile in human  chronic heart failure | Oncotarget
Identification of cardiac-related circulating microRNA profile in human chronic heart failure | Oncotarget

MicroRNAs as Potential Predictors of Postoperative AF | ECR Journal
MicroRNAs as Potential Predictors of Postoperative AF | ECR Journal

Circulating MicroRNAs: Potential and Emerging Biomarkers for Diagnosis of  Cardiovascular and Cerebrovascular Diseases
Circulating MicroRNAs: Potential and Emerging Biomarkers for Diagnosis of Cardiovascular and Cerebrovascular Diseases

Frontiers | Circulating MicroRNAs: Biogenesis and Clinical Significance in  Acute Myocardial Infarction
Frontiers | Circulating MicroRNAs: Biogenesis and Clinical Significance in Acute Myocardial Infarction

Increased MicroRNA-1 and MicroRNA-133a Levels in Serum of Patients With  Cardiovascular Disease Indicate Myocardial Damage | Circulation:  Cardiovascular Genetics
Increased MicroRNA-1 and MicroRNA-133a Levels in Serum of Patients With Cardiovascular Disease Indicate Myocardial Damage | Circulation: Cardiovascular Genetics

Non-canonical features of microRNAs: paradigms emerging from cardiovascular  disease | Nature Reviews Cardiology
Non-canonical features of microRNAs: paradigms emerging from cardiovascular disease | Nature Reviews Cardiology